Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

9480	Companies
185523	Keywords
117911	Articles
99370	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 03/27/2025 at 13:35, 8 months 9 days ago

Jaguar Health Secures FDA Meeting to Discuss Crofelemer Results in Breast Cancer Trial

Crofelemer Jaguar Health Breast Cancer FDA Meeting OnTarget Study
PRESS RELEASE

published on 03/27/2025 at 13:30, 8 months 9 days ago

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study
Napo Pharmaceuticals presents statistically significant responder analysis results for crofelemer in breast cancer patients at San Antonio Breast Cancer Symposium and MASCC, FDA Type C Meeting scheduled for 2025

Napo Pharmaceuticals Crofelemer Breast Cancer FDA Meeting Responder Analysis
BRIEF

published on 03/26/2025 at 16:05, 8 months 10 days ago

Jaguar Health to Present at Emerging Growth Conference and Host Investor Webcast

Investor Webcast Jaguar Health Emerging Growth Conference Crofelemer Development Q4 2024 Financials
PRESS RELEASE

published on 03/26/2025 at 16:00, 8 months 10 days ago

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts
Jaguar Health, Inc. announces virtual presentation and investor webcast dates. Company to file annual report on March 31, 2025. Lisa Conte to discuss upcoming developments

Virtual Presentation Investor Webcast Annual Report Lisa Conte Jaguar Health Inc.
BRIEF

published on 03/26/2025 at 14:30, 8 months 10 days ago

Jaguar Health Secures $3.448 Million in Bridge Financing

Investment Bridge Financing Jaguar Health Convertible Notes Stock Warrants
PRESS RELEASE

published on 03/26/2025 at 14:25, 8 months 10 days ago

Jaguar Health CEO, Board Members, Other C-Suite Members, and Institutional and Accredited Investors Invest in $3.448 Million Bridge Financing Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announced a private placement of convertible promissory notes to selected investors for working capital. H.C. Wainwright & Co. is the placement agent

Private Placement Working Capital Convertible Notes Jaguar Health Inc. H.C. Wainwright & Co.
BRIEF

published on 03/18/2025 at 13:35, 8 months 18 days ago

Jaguar Health Announces Reverse Stock Split

Reverse Stock Split Jaguar Health Nasdaq Compliance Institutional Investors Equiniti Trust
PRESS RELEASE

published on 03/18/2025 at 13:30, 8 months 18 days ago

Jaguar Health, Inc. Announces Reverse Stock Split
Jaguar Health, Inc. announces reverse stock split approval at Special Meeting of Stockholders to comply with Nasdaq's listing standards. Shares to trade on split-adjusted basis starting March 24, 2025

Shareholders Reverse Stock Split Nasdaq Listing Jaguar Health Stock Market
BRIEF

published on 03/13/2025 at 21:20, 8 months 22 days ago

Jaguar Health Approves Proposals and Anticipates Key Developments in 2025

Crofelemer Clinical Trials Jaguar Health Regulatory Approval Rare Diseases
PRESS RELEASE

published on 03/13/2025 at 21:15, 8 months 22 days ago

Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders
Jaguar Health announces voting results of Special Meeting of Stockholders and expect first results in Q2 2025 for crofelemer trials in rare diseases. FDA meeting anticipated for Phase 3 OnTarget trial in breast cancer patients

Special Meeting Jaguar Health Rare Diseases Crofelemer Trials FDA Meeting

Accesswire

Published on 12/05/2025 at 18:45, 5 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 30 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 50 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 35 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 50 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:26, 23 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 34 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 58 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 4 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 50 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 32 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 39 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 10 hours 5 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 1 day ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 1 day 1 hour ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE